Application 203702

Type: ANDA
Sponsor: QILU

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	CEFTRIAXONE	CEFTRIAXONE SODIUM	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	EQ 250MG BASE/VIAL	No	No
002	CEFTRIAXONE	CEFTRIAXONE SODIUM	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	EQ 500MG BASE/VIAL	No	No
003	CEFTRIAXONE	CEFTRIAXONE SODIUM	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	EQ 1GM BASE/VIAL	No	No
004	CEFTRIAXONE	CEFTRIAXONE SODIUM	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	EQ 2GM BASE/VIAL	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A203702-001	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29
A203702-002	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29
A203702-003	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29
A203702-004	CEFTRIAXONE	CEFTRIAXONE SODIUM	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A203702-001	AP
A203702-002	AP
A203702-003	AP
A203702-004	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-001	CEFTRIAXONE	EQ 250MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-002	CEFTRIAXONE	EQ 500MG BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-003	CEFTRIAXONE	EQ 1GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-004	CEFTRIAXONE	EQ 2GM BASE/VIAL	INJECTABLE / INTRAMUSCULAR, INTRAVENOUS	AP	2016-06-29	`d8e5a09893c0…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A203702-001	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203702-002	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203702-003	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203702-004	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203702-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203702-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203702-003	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203702-004	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-003	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203702-004	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203702-001	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203702-002	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203702-003	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203702-004	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-001	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-002	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-003	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203702-004	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-001	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-002	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-003	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203702-004	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-001	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-002	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-003	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203702-004	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-001	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-002	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-003	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203702-004	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-001	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-002	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-003	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203702-004	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-001	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-002	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-003	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203702-004	AP	1	`d8e5a09893c0…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Sportpharm LLC	85ce4f8b-77e0-48bf-9f57-93f1478befa2	2026-04-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Sportpharm LLC	9a937e47-8c36-4656-83e1-b3c18ed9bac3	2026-04-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Qilu Pharmaceutical Co., Ltd.	4cdf0743-c62b-4969-b9c9-4c6400644f6c	2026-02-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702 ndc (product): 67184-1005 ndc (product): 67184-1006 ndc (product): 67184-1008 ndc (product): 67184-1007
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	A-S Medication Solutions	53415af6-4072-4339-83e2-d870ae02a0e2	2024-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702 ndc (product): 50090-3838
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Proficient Rx LP	790279d4-2456-4091-abec-960b78885432	2024-02-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Asclemed USA, Inc.	f01cf0e5-caaf-4759-ba21-50f3aceff523	2023-09-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Apotex Corp.	5116231f-82d1-44be-b08e-560c9a50e5c5	2023-08-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702 ndc (product): 60505-6148 ndc (product): 60505-6151 ndc (product): 60505-6149 ndc (product): 60505-6152
Ceftriaxone Sodium	CEFTRIAXONE SODIUM	Proficient Rx LP	42ba7a9d-7d2b-4eac-af59-897151a8c924	2022-05-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 203702 application number: ANDA203702 ndc (product): 71205-545

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 42 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
50090-3810	Ceftriaxone Sodium	Ceftriaxone Sodium	A-S Medication Solutions	ANDA	Current
50090-3810	Ceftriaxone Sodium	Ceftriaxone Sodium	A-S Medication Solutions	ANDA	Current
50090-3838	Ceftriaxone Sodium	Ceftriaxone Sodium	A-S Medication Solutions	ANDA	Current
50090-3838	Ceftriaxone Sodium	Ceftriaxone Sodium	A-S Medication Solutions	ANDA	Current
50090-4689	Ceftriaxone Sodium	Ceftriaxone Sodium	A-S Medication Solutions	ANDA	Current
50090-4689	Ceftriaxone Sodium	Ceftriaxone Sodium	A-S Medication Solutions	ANDA	Current
50090-4689	Ceftriaxone Sodium	Ceftriaxone Sodium	A-S Medication Solutions	ANDA	Current
50090-4978	Ceftriaxone Sodium	Ceftriaxone Sodium	A-S Medication Solutions	ANDA	Current
50090-4978	Ceftriaxone Sodium	Ceftriaxone Sodium	A-S Medication Solutions	ANDA	Current
52584-148	Ceftriaxone	Ceftriaxone Sodium	General Injectables and Vaccines, Inc.	ANDA	Current
52584-148	Ceftriaxone	Ceftriaxone Sodium	General Injectables and Vaccines, Inc.	ANDA	Current
60505-6148	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6148	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6148	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6148	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6148	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6148	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6149	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6149	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6149	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6149	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6149	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6149	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6151	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6151	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6151	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6151	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6151	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6151	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6152	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6152	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6152	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6152	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6152	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
60505-6152	Ceftriaxone Sodium	Ceftriaxone Sodium	Apotex Corp.	ANDA	Current
67184-1005	Ceftriaxone Sodium	Ceftriaxone Sodium	Qilu Pharmaceutical Co., Ltd.	ANDA	Current
67184-1006	Ceftriaxone Sodium	Ceftriaxone Sodium	Qilu Pharmaceutical Co., Ltd.	ANDA	Current
67184-1007	Ceftriaxone Sodium	Ceftriaxone Sodium	Qilu Pharmaceutical Co., Ltd.	ANDA	Current
67184-1008	Ceftriaxone Sodium	Ceftriaxone Sodium	Qilu Pharmaceutical Co., Ltd.	ANDA	Current
70518-3099	Ceftriaxone Sodium	Ceftriaxone Sodium	REMEDYREPACK INC.	ANDA	Current
71205-545	Ceftriaxone Sodium	Ceftriaxone Sodium	Proficient Rx LP	ANDA	Current
71205-545	Ceftriaxone Sodium	Ceftriaxone Sodium	Proficient Rx LP	ANDA	Current